Diamond Citra Propertindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Diamond Citra Propertindo Tbk. trades at Rp50 (market cap 371.58B, 215.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 71K 24h volume). The key difference: Diamond Citra Propertindo Tbk. is far larger — about 2.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Diamond Citra Propertindo Tbk. is more actively traded (215.4K versus 71K). Which is the better fit depends on your goals.
| DADA | OBAT | |
|---|---|---|
Market Cap | 371.58B | 167.37B |
Volume | 215.4K | 71K |
Lot | 2.15K | 710 |
Turnover | 10.77M | 17.51M |
Average Price | 50 | 246.63 |
Value | 10.77M | 17.51M |
Indicative Equilibrium Price | 50 | 246 |
Indicative Equilibrium Volume | 31 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Diamond Citra Propertindo Tbk ("the Company") was established based on Deed of Establishment No. 86 December 29, 2014, by Dewi Kusumawati, S.H., notary in Jakarta.
Read more on DADA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →